CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Atomoxetine

盐酸托莫西汀 杂质对照品Atomoxetine Impurities

EPUSP59 个杂质条目59 impurity entries

本页汇总 盐酸托莫西汀 的 59 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 59 impurity reference standards of Atomoxetine with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 盐酸托莫西汀(Atomoxetine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesA quality by design approach to impurity method development for atomoxetine hydrochloride (LY139603)
    Journal of pharmaceutical and biomedical analysis · 2008 · Gavin PF, Olsen BA  ·  PMID 18082352  ·  DOI
  2. 杂质研究Impurity studiesDetermination of the enantiomer and positional isomer impurities in atomoxetine hydrochloride with liquid chromatography using polysaccharide chiral stationary phases
    Journal of pharmaceutical and biomedical analysis · 2006 · Sellers JA et al.  ·  PMID 16533585  ·  DOI
  3. 杂质研究Impurity studiesDevelopment and validation of a stability-indicating RP-HPLC method for determination of atomoxetine hydrochloride in tablets
    Journal of AOAC International · 2010 · Patel SK, Patel NJ  ·  PMID 20922953
  4. 分析方法Analytical MethodsDevelopment and validation of a rapid LC-MS/MS method for methylphenidate, atomoxetine, and their metabolites with application to pediatric pharmacokinetics
    Journal of pharmaceutical and biomedical analysis · 2026 · Eryavuz Onmaz D et al.  ·  PMID 41435525  ·  DOI
  5. 分析方法Analytical MethodsDevelopment of a Sensitive Fluorimetric Method for Atomoxetine Determination in Tablets and Plasma Using a Dansyl Chloride Derivatization Approach
    Luminescence : the journal of biological and chemical luminescence · 2025 · El Hamd MA et al.  ·  PMID 40913240  ·  DOI

盐酸托莫西汀 —— 原料药与杂质对照品Atomoxetine — drug substance & impurities

共 60 个条目(含原料药本体)60 items incl. the drug substance
Atomoxetine structure
EP原料药 APIAPI
托莫西汀Atomoxetine
Atomoxetine
CAS No.83015-26-3
Chemical FormulaC17H21NO
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine EP Impurity A HCl ((R)-Isomer) structure
EPA
盐酸托莫西汀杂质11Atomoxetine EP Impurity A HCl ((R)-Isomer)
Atomoxetine EP Impurity A HCl ((R)-Isomer)
CAS No.1212215-97-8
Chemical FormulaC16H19NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine EP Impurity A HCl structure
EPA
盐酸托莫西汀杂质1 (盐酸托莫西汀EP杂质A 盐酸盐)Atomoxetine EP Impurity A HCl
Atomoxetine EP Impurity A HCl
CAS No.873310-33-9
Chemical FormulaC16H19NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Atomoxetine EP Impurity A structure
EPA
N-Nitroso Atomoxetine EP Impurity A
CAS No.—
Chemical FormulaC16H18N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine EP Impurity B HCl ((S)-Atomoxetine HCl) structure
EPB
盐酸托莫西汀杂质2 (盐酸托莫西汀EP杂质B 盐酸盐)Atomoxetine EP Impurity B HCl ((S)-Atomoxetine HCl)
Atomoxetine EP Impurity B HCl ((S)-Atomoxetine HCl)
CAS No.82857-39-4
Chemical FormulaC17H21NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Atomoxetine EP Impurity B (N-Nitroso (S)-Atomoxetine) structure
EPB
N-Nitroso Atomoxetine EP Impurity B (N-Nitroso (S)-Atomoxetine)
CAS No.—
Chemical FormulaC17H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine EP Impurity C HCl (Atomoxetine USP Related Compound C (R-Isomer)) structure
EPC
盐酸托莫西汀杂质3 (盐酸托莫西汀EP杂质C 盐酸盐) (托莫西汀USP相关化合物C 盐酸盐)Atomoxetine EP Impurity C HCl (Atomoxetine USP Related Compound C (R-Isomer))
Atomoxetine EP Impurity C HCl (Atomoxetine USP Related Compound C (R-Isomer))
CAS No.1643684-06-3
Chemical FormulaC17H21NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
rac-Atomoxetine EP Impurity C HCl (Atomoxetine USP Related Compound C) structure
EPC
盐酸托莫西汀杂质15 (消旋盐酸托莫西汀EP杂质C 盐酸盐) (消旋托莫西汀USP相关化合物C 盐酸盐)rac-Atomoxetine EP Impurity C HCl (Atomoxetine USP Related Compound C)
rac-Atomoxetine EP Impurity C HCl (Atomoxetine USP Related Compound C)
CAS No.873310-31-7
Chemical FormulaC17H21NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine EP Impurity D HCl (Atomoxetine USP Related Compound B (R-Isomer)) structure
EPD
盐酸托莫西汀杂质4 (盐酸托莫西汀EP杂质D 盐酸盐)Atomoxetine EP Impurity D HCl (Atomoxetine USP Related Compound B (R-Isomer))
Atomoxetine EP Impurity D HCl (Atomoxetine USP Related Compound B (R-Isomer))
CAS No.1643684-05-2
Chemical FormulaC17H21NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
rac-Atomoxetine EP Impurity D HCl (Atomoxetine USP Related Compound B) structure
EPD
盐酸托莫西汀杂质38rac-Atomoxetine EP Impurity D HCl (Atomoxetine USP Related Compound B)
rac-Atomoxetine EP Impurity D HCl (Atomoxetine USP Related Compound B)
CAS No.873310-28-2
Chemical FormulaC17H21NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Atomoxetine EP Impurity D structure
EPD
N-Nitroso Atomoxetine EP Impurity D
CAS No.—
Chemical FormulaC17H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine EP Impurity F HCl structure
EPF
盐酸托莫西汀EP杂质FAtomoxetine EP Impurity F HCl
Atomoxetine EP Impurity F HCl
CAS No.2727370-25-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Atomoxetine EP Impurity F structure
EPF
N-Nitroso Atomoxetine EP Impurity F
CAS No.—
Chemical FormulaC17H19FN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine EP Impurity G DiHCl (Mixture of Diastereomers) structure
EPG
盐酸托莫西汀EP杂质GAtomoxetine EP Impurity G DiHCl (Mixture of Diastereomers)
Atomoxetine EP Impurity G DiHCl (Mixture of Diastereomers)
CAS No.—
Chemical FormulaC27H34N2O2.2HCl
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Atomoxetine EP Impurity G structure
EPG
N-Nitroso Atomoxetine EP Impurity G
CAS No.—
Chemical FormulaC27H33N3O3
Purity>95%询价On request
10mg25mg50mg100mg
N,N-Dinitroso Atomoxetine EP Impurity G structure
EPG
N,N-Dinitroso Atomoxetine EP Impurity G
CAS No.—
Chemical FormulaC27H32N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine EP Impurity H (S-Isomer) structure
EPH
盐酸托莫西汀EP杂质HAtomoxetine EP Impurity H (S-Isomer)
Atomoxetine EP Impurity H (S-Isomer)
CAS No.114133-37-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine EP Impurity H (R-Isomer) structure
EPH
盐酸托莫西汀杂质19Atomoxetine EP Impurity H (R-Isomer)
Atomoxetine EP Impurity H (R-Isomer)
CAS No.115290-81-8
Chemical FormulaC10H15NO
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Atomoxetine EP Impurity H (S-Isomer) structure
EPH
N-Nitroso Atomoxetine EP Impurity H (S-Isomer)
CAS No.—
Chemical FormulaC10H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Atomoxetine EP Impurity H (R-Isomer) structure
EPH
N-Nitroso Atomoxetine EP Impurity H (R-Isomer)
CAS No.—
Chemical FormulaC10H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine EP Impurity B-d3 HCl ((S)-Atomoxetine-d3 HCl) structure
EPB-D3
盐酸托莫西汀杂质2-d3 (盐酸托莫西汀EP杂质B 盐酸盐-d3 )Atomoxetine EP Impurity B-d3 HCl ((S)-Atomoxetine-d3 HCl)
Atomoxetine EP Impurity B-d3 HCl ((S)-Atomoxetine-d3 HCl)
CAS No.1217703-95-1
Chemical FormulaC17H18D3NO·HCl
Purity>95%询价On request
N-Nitroso Atomoxetine USP Related Compound B structure
USPB
N-Nitroso Atomoxetine USP Related Compound B
CAS No.—
Chemical FormulaC17H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Atomoxetine structure
—
盐酸托莫西汀杂质41 (N-亚硝基盐酸托莫西汀)N-Nitroso Atomoxetine
N-Nitroso Atomoxetine
CAS No.3028194-77-3
Chemical FormulaC17H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
4-Hydroxy Atomoxetine Oxalate structure
—
4-Hydroxy Atomoxetine Oxalate
CAS No.457634-21-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
4’-Hydroxy Atomoxetine Glucuronide structure
—
盐酸托莫西汀杂质30 (4’-羟基盐酸托莫西汀葡糖苷酸)4’-Hydroxy Atomoxetine Glucuronide
4’-Hydroxy Atomoxetine Glucuronide
CAS No.540729-08-6
Chemical FormulaC23H29NO8
Purity>95%询价On request
10mg25mg50mg100mg
rac-N-Desmethyl Atomoxetine HCl structure
—
盐酸托莫西汀杂质31rac-N-Desmethyl Atomoxetine HCl
rac-N-Desmethyl Atomoxetine HCl
CAS No.881995-46-6
Chemical FormulaC16H19NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
4-Hydroxy Atomoxetine (S-Isomer) Oxalate structure
—
4-Hydroxy Atomoxetine (S-Isomer) Oxalate
CAS No.—
Chemical FormulaC17H21NO2.C2H2O4
Purity>95%询价On request
10mg25mg50mg100mg
4'-Hydroxy Atomoxetine-d3 Hemioxalate structure
—
4'-Hydroxy Atomoxetine-d3 Hemioxalate
CAS No.—
Chemical FormulaC17H18D3NO2.0.5C2H2O4
Purity>95%询价On request
N-Nitroso Atomoxetine-d3 structure
—
N-Nitroso Atomoxetine-d3
CAS No.—
Chemical FormulaC17H17D3N2O2
Purity>95%询价On request
Atomoxetine Glucose Adduct I structure
—
Atomoxetine Glucose Adduct I
CAS No.—
Chemical FormulaC23H31NO6
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Glucose Adduct II structure
—
Atomoxetine Glucose Adduct II
CAS No.—
Chemical FormulaC23H31NO6
Purity>95%询价On request
10mg25mg50mg100mg
4’-Hydroxy Atomoxetine-d3 Glucuronide structure
—
4’-Hydroxy Atomoxetine-d3 Glucuronide
CAS No.—
Chemical FormulaC23H26NO8D3
Purity>95%询价On request
Atomoxetine Impurity 1 HCl structure
1
盐酸托莫西汀杂质18Atomoxetine Impurity 1 HCl
Atomoxetine Impurity 1 HCl
CAS No.42064-62-0
Chemical FormulaC18H23NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 2 structure
2
盐酸托莫西汀杂质2Atomoxetine Impurity 2
Atomoxetine Impurity 2
CAS No.—
Chemical FormulaC18H22N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 4 HCl structure
4
盐酸托莫西汀杂质4Atomoxetine Impurity 4 HCl
Atomoxetine Impurity 4 HCl
CAS No.—
Chemical FormulaC16H19NO.HCl
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 5 structure
5
盐酸托莫西汀杂质20Atomoxetine Impurity 5
Atomoxetine Impurity 5
CAS No.2376668-89-0
Chemical FormulaC18H21NO2
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 6 (Mixture of Diastereomers) structure
6
盐酸托莫西汀杂质6Atomoxetine Impurity 6 (Mixture of Diastereomers)
Atomoxetine Impurity 6 (Mixture of Diastereomers)
CAS No.—
Chemical FormulaC33H37NO2
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 7 HCl structure
7
盐酸托莫西汀杂质7Atomoxetine Impurity 7 HCl
Atomoxetine Impurity 7 HCl
CAS No.—
Chemical FormulaC26H31NO2.HCl
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 8 HCl structure
8
盐酸托莫西汀杂质8Atomoxetine Impurity 8 HCl
Atomoxetine Impurity 8 HCl
CAS No.—
Chemical FormulaC19H25NO2.HCl
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 9 HCl structure
9
盐酸托莫西汀杂质9Atomoxetine Impurity 9 HCl
Atomoxetine Impurity 9 HCl
CAS No.1011-59-2
Chemical FormulaC11H17Cl2N
Purity>95%现货In stock
10mg25mg50mg100mg
Atomoxetine Impurity 10 HCl structure
10
盐酸托莫西汀杂质25Atomoxetine Impurity 10 HCl
Atomoxetine Impurity 10 HCl
CAS No.128036-32-8
Chemical FormulaC10H14ClN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 11 structure
11
盐酸托莫西汀杂质11Atomoxetine Impurity 11
Atomoxetine Impurity 11
CAS No.—
Chemical FormulaC18H20ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 12 Oxalate structure
12
盐酸托莫西汀杂质12Atomoxetine Impurity 12 Oxalate
Atomoxetine Impurity 12 Oxalate
CAS No.—
Chemical FormulaC24H27NO.C2H2O4
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 13 structure
13
盐酸托莫西汀杂质28Atomoxetine Impurity 13
Atomoxetine Impurity 13
CAS No.5409-62-1
Chemical FormulaC17H19NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 14 HCl structure
14
盐酸氟西汀杂质6Atomoxetine Impurity 14 HCl
Atomoxetine Impurity 14 HCl
CAS No.116939-14-1
Chemical FormulaC10H13N·HCl
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Atomoxetine Impurity 14 structure
14
N-Nitroso Atomoxetine Impurity 14
CAS No.—
Chemical FormulaC10H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 15 structure
15
盐酸托莫西汀杂质55Atomoxetine Impurity 15
Atomoxetine Impurity 15
CAS No.881995-45-5
Chemical FormulaC19H23NO2
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 16 structure
16
盐酸托莫西汀杂质16Atomoxetine Impurity 16
Atomoxetine Impurity 16
CAS No.95-48-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 17 HCl structure
17
盐酸托莫西汀杂质17Atomoxetine Impurity 17 HCl
Atomoxetine Impurity 17 HCl
CAS No.—
Chemical FormulaC18H23NO.HCl
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 18 structure
18
盐酸托莫西汀杂质18Atomoxetine Impurity 18
Atomoxetine Impurity 18
CAS No.—
Chemical FormulaC19H23NO2
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 19 (R-Isomer) structure
19
盐酸达泊西汀杂质41Atomoxetine Impurity 19 (R-Isomer)
Atomoxetine Impurity 19 (R-Isomer)
CAS No.100306-33-0
Chemical FormulaC9H11ClO
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 19 structure
19
盐酸达泊西汀杂质60Atomoxetine Impurity 19
Atomoxetine Impurity 19
CAS No.18776-12-0
Chemical FormulaC9H11ClO
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 20 structure
20
盐酸托莫西汀杂质20Atomoxetine Impurity 20
Atomoxetine Impurity 20
CAS No.114446-47-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 21 structure
21
盐酸托莫西汀杂质62Atomoxetine Impurity 21
Atomoxetine Impurity 21
CAS No.1212823-01-2
Chemical FormulaC16H19NO
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 22 structure
22
盐酸托莫西汀杂质22Atomoxetine Impurity 22
Atomoxetine Impurity 22
CAS No.—
Chemical FormulaC17H21NO2
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 23 (S)-Mandelate structure
23
盐酸托莫西汀杂质60 L-扁桃酸盐Atomoxetine Impurity 23 (S)-Mandelate
Atomoxetine Impurity 23 (S)-Mandelate
CAS No.1007832-68-9
Chemical FormulaC24H27NO·C8H8O3
Purity>95%询价On request
10mg25mg50mg100mg
Atomoxetine Impurity 24 Bromide structure
24
Atomoxetine Impurity 24 Bromide
CAS No.—
Chemical FormulaC31H34NO.Br
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

盐酸托莫西汀 —— 研究文献与合成路线Atomoxetine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 盐酸托莫西汀 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Atomoxetine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. A quality by design approach to impurity method development for atomoxetine hydrochloride (LY139603)
    Gavin PF, Olsen BA · Journal of pharmaceutical and biomedical analysis · 2008 · 被引 31cited 31
  2. Determination of the enantiomer and positional isomer impurities in atomoxetine hydrochloride with liquid chromatography using polysaccharide chiral stationary phases
    Sellers JA, Olsen BA, Owens PK, et al. · Journal of pharmaceutical and biomedical analysis · 2006 · 被引 10cited 10
  3. AN ISOLATED ATOMOXETINE IMPURITY, PROCESSES FOR THE PREPARATION OF ATOMOXETINE IMPURITIES AND THEIR USE AS REFERENCE STANDARDS
    CASTELLI EUGENIO, VAILATI ALESSANDRA · 2008
  4. Isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards
    CASTELLI EUGENIO, VAILATI ALESSANDRA · 2008
  5. Spectrophotometric and spectrofluorimetric determination of atomoxetine in pharmaceutical preparations
    Ulu ST · Die Pharmazie · 2011 · 被引 7cited 7

合成与制备工艺专利Synthesis & process patents

  1. NOVEL PROCESS FOR THE PREPARATION OF 4-HYDROXY ATOMOXETINE
    VELLANKI SIVA RAMA PRASAD, SAHU ARABINDA, KATUKURI ARAVIND KUMAR, PILLI RAMAKRISHNA, et al. · 公开号 WO2011027359WO2011027359 · 2011
  2. METHOD FOR PREPARING ATOMOXETINE
    CHEN BO-FONG, LI YAN-WEI, YEH JINUN-BAN, WONG WEI-CHYUN · 公开号 US2011319664US2011319664 · 2011
  3. AN IMPROVED PROCESS FOR SYNTHESIZING HIGHLY PURE ATOMOXETINE
    SRINIVASAN CHIDAMBARAM VENKATE, JOHAR PERMINDER SINGH, WADHWA LALIT · 公开号 WO2009141833WO2009141833 · 2009
  4. PROCESS FOR PREPARING ATOMOXETINE HYDROCHLORIDE
    PATEL VIPUL KANTIBHAI, KUMAR RAJIV, DHAR DWIVEDI SHRIPRAKASH · 公开号 WO2008062473WO2008062473 · 2008
  5. AN ISOLATED ATOMOXETINE IMPURITY, PROCESSES FOR THE PREPARATION OF ATOMOXETINE IMPURITIES AND THEIR USE AS REFERENCE STANDARDS
    CASTELLI EUGENIO, VAILATI ALESSANDRA · 公开号 KR20070001250KR20070001250 · 2007

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

盐酸托莫西汀 杂质谱研究要点Atomoxetine — impurity profiling notes

下面这些是拿到 盐酸托莫西汀 的 60 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 60 impurity entries for Atomoxetine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances